Phenotypes associated with this allele
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Casp8em1Hbz mutation
(0 available);
any
Casp8 mutation
(42 available)
|
|
|
immune system
|
• mild decrease of CD8+ T cell percentage in spleen and bone marrow
|
homeostasis/metabolism
cellular
|
• resistance to apoptosis in mouse dermal fibroblasts (MDFs) after treatment with RIPK3 kinase inhibitor GSK872 in vitro
• compromised apoptosis in thymocytes in vitro and increased survival in vivo after treatment with anti-Fas antibody
|
hematopoietic system
N |
• normal B cells and myeloid cells in spleen, lymph nodes and bone marrow
|
|
• mild decrease of CD8+ T cell percentage in spleen and bone marrow
|
growth/size/body
mortality/aging
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Casp8em1Hbz mutation
(0 available);
any
Casp8 mutation
(42 available)
Ripk3tm1Xidw mutation
(0 available);
any
Ripk3 mutation
(31 available)
|
|
|
immune system
|
• increased CD11b+ granulocytes in spleen
• normal in bone marrow
|
|
• increased percentage of myeloid-derived CD11b+ cells in spleen and bone marrow
|
|
• in spleen
• normal in bone marrow
|
|
• decreased white blood cell number in peripheral blood
• normal monocyte and granulocyte numbers in peripheral blood
|
|
• severe reduction in CD19+ B cell numbers in spleen, bone marrow and peripheral blood
|
|
• reduced B220+ IgM+ and B220+ CD19+ B cell numbers in spleen, bone marrow and peripheral blood
|
|
• severe reduction in CD3+ T cell numbers in spleen, bone marrow and peripheral blood
• severe reduction in CD3+ CD4+ CD8- and CD3+ CD4- CD8+ T cell in spleen, bone marrow and peripheral blood
|
hematopoietic system
|
• increased CD11b+ granulocytes in spleen
• normal in bone marrow
|
|
• increased percentage of myeloid-derived CD11b+ cells in spleen and bone marrow
|
|
• in spleen
• normal in bone marrow
|
|
• decreased white blood cell number in peripheral blood
• normal monocyte and granulocyte numbers in peripheral blood
|
|
• severe reduction in CD19+ B cell numbers in spleen, bone marrow and peripheral blood
|
|
• reduced B220+ IgM+ and B220+ CD19+ B cell numbers in spleen, bone marrow and peripheral blood
|
|
• severe reduction in CD3+ T cell numbers in spleen, bone marrow and peripheral blood
• severe reduction in CD3+ CD4+ CD8- and CD3+ CD4- CD8+ T cell in spleen, bone marrow and peripheral blood
|
growth/size/body
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Casp8em1Hbz mutation
(0 available);
any
Casp8 mutation
(42 available)
Ripk1em4Hbz mutation
(0 available);
any
Ripk1 mutation
(31 available)
Ripk3tm1Xidw mutation
(0 available);
any
Ripk3 mutation
(31 available)
|
|
|
growth/size/body
integument
|
• focal cutaneous lesions
|
mortality/aging
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Casp8em1Hbz mutation
(0 available);
any
Casp8 mutation
(42 available)
Ripk1em1Hbz mutation
(0 available);
any
Ripk1 mutation
(31 available)
Ripk3tm1Xidw mutation
(0 available);
any
Ripk3 mutation
(31 available)
|
|
|
hematopoietic system
|
• decreased white blood cell number in peripheral blood
• normal monocyte and granulocyte numbers in peripheral blood
|
|
• reduced B220+ IgM+ and B220+ CD19+ B cell numbers in spleen and bone marrow
|
|
• severe reduction in CD3+ CD4+ CD8- and CD3+ CD4- CD8+ T cell in spleen and bone marrow
|
immune system
|
• decreased white blood cell number in peripheral blood
• normal monocyte and granulocyte numbers in peripheral blood
|
|
• reduced B220+ IgM+ and B220+ CD19+ B cell numbers in spleen and bone marrow
|
|
• severe reduction in CD3+ CD4+ CD8- and CD3+ CD4- CD8+ T cell in spleen and bone marrow
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Casp8em1Hbz mutation
(0 available);
any
Casp8 mutation
(42 available)
Mlklem1Hbz mutation
(0 available);
any
Mlkl mutation
(32 available)
|
|
|
immune system
|
• increased CD11b+ granulocytes in spleen
• normal in bone marrow
|
|
• increased percentage of myeloid-derived CD11b+ cells in spleen and bone marrow
|
|
• in spleen
• normal in bone marrow
|
|
• decreased white blood cell number in peripheral blood
• normal monocyte and granulocyte numbers in peripheral blood
|
|
• severe reduction in CD19+ B cell numbers in spleen, bone marrow and peripheral blood
|
|
• reduced B220+ IgM+ and B220+ CD19+ B cell numbers in peripheral blood
|
|
• severe reduction in CD3+ T cell numbers in spleen, bone marrow and peripheral blood
• severe reduction in CD3+ CD4+ CD8- and CD3+ CD4- CD8+ T cell in peripheral blood
|
hematopoietic system
|
• increased CD11b+ granulocytes in spleen
• normal in bone marrow
|
|
• increased percentage of myeloid-derived CD11b+ cells in spleen and bone marrow
|
|
• in spleen
• normal in bone marrow
|
|
• decreased white blood cell number in peripheral blood
• normal monocyte and granulocyte numbers in peripheral blood
|
|
• severe reduction in CD19+ B cell numbers in spleen, bone marrow and peripheral blood
|
|
• reduced B220+ IgM+ and B220+ CD19+ B cell numbers in peripheral blood
|
|
• severe reduction in CD3+ T cell numbers in spleen, bone marrow and peripheral blood
• severe reduction in CD3+ CD4+ CD8- and CD3+ CD4- CD8+ T cell in peripheral blood
|
growth/size/body